Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-04-19FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)
FDA approved a supplemental application for fluoxetine hydrochloride from Time Cap Laboratories, Inc., updating the regulatory status of thi…
-
FDA approval · 2012-04-18FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc.
-
FDA approval · 2012-04-10FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for paroxetine hydrochloride submitted by Apotex Corp.
-
FDA approval · 2012-04-02FDA Approved: ESCITALOPRAM OXALATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves an original application for escitalopram oxalate as a generic drug, manufactured by Rising Pharma Holdings, Inc.
-
FDA approval · 2012-03-28FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Bupropion Hydrochloride from Apnar Pharma LP, confirming approval of a generic formulation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's generic quetiapine tablets through an Original Application. Quetiapine is approved for schizophrenia, bipolar disorder, …
-
FDA approval · 2012-03-27FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, granting approval for a generic product under an A…
-
FDA approval · 2012-03-27FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Celexa (citalopram) submitted by Allergan, Inc.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Accord Healthcare Inc.)
FDA approved a generic Quetiapine product from Accord Healthcare Inc. under ANDA202152 (Original Application).
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original application for a generic version of quetiapine fumarate from Sun Pharmaceutical Industries.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original-application generic quetiapine fumarate, a generic version of the antipsychotic queti…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (BluePoint Laboratories)
FDA approved the original application for quetiapine fumarate as a generic drug, with BluePoint Laboratories listed as the applicant.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic quetiapine fumarate (ANDA 090120) via an Original Application approval. The generic is…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic quetiapine fumarate from Aurobindo Pharma Limited. This adds a generic option for the…
-
FDA approval · 2012-03-14FDA Approved: ESCITALOPRAM OXALATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for a generic escitalopram oxalate product, expanding access to escitalopram …
-
FDA approval · 2012-03-07FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lithium carbonate submitted by Camber Pharmaceuticals, Inc.
-
FDA approval · 2012-02-28FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approves a supplemental application for a generic fluoxetine hydrochloride product from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-02-28FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves the supplemental application for fluoxetine from Alembic Pharmaceuticals Limited, enabling the generic fluoxetine product to be…
-
FDA approval · 2012-02-21FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for bupropion hydrochloride (generic), confirming approval fo…
-
FDA approval · 2011-12-27FDA Approved: REMERON — Supplemental Application (Organon LLC)
FDA approves a supplemental application for REMERON (mirtazapine) submitted by Organon LLC, resulting in updated labeling for the product.
-
FDA approval · 2011-12-27FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application from Mylan Pharmaceuticals for paroxetine hydrochloride hemihydrate, authorizing a generic version o…
-
FDA approval · 2011-12-15FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to manufacture and market paroxetine hydrochloride as a generic antidepressant.
-
FDA approval · 2011-11-22FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)
FDA approved a supplemental application for fluoxetine hydrochloride from Time Cap Laboratories, Inc., enabling the generic product Fluoxeti…
-
FDA approval · 2011-11-10FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved bupropion hydrochloride from Upsher-Smith Laboratories in an original application, authorizing its use for major depressive dis…